SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000819050-20-000083
Filing Date
2020-04-14
Accepted
2020-04-14 17:10:06
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 a202004424b5nexgen.htm 424B5 362526
2 bbi1.jpg GRAPHIC 6568
3 bbi2.jpg GRAPHIC 6568
4 bbi3.jpg GRAPHIC 6568
  Complete submission text file 0000819050-20-000083.txt   391046
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-236353 | Film No.: 20791888
SIC: 2836 Biological Products, (No Diagnostic Substances)